176 related articles for article (PubMed ID: 19671288)
1. [Abnormal expression of transcription factors LYL1 and LMO2 and interaction between them in myeloid leukemia].
Meng YS; Wei R; Ai GW; Meng XQ; Zhang YX
Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(13):890-3. PubMed ID: 19671288
[TBL] [Abstract][Full Text] [Related]
2. [Expression of transcription factor LYL1 in leukemia and its possible role in leukemogenesis].
Meng YS; Zhang YX; Ai GW; Meng XQ; Liu W; Wei R; Jiang W
Zhonghua Xue Ye Xue Za Zhi; 2008 Nov; 29(11):749-52. PubMed ID: 19176012
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic potential of the transcription factor LYL1 in acute myeloblastic leukemia.
Meng YS; Khoury H; Dick JE; Minden MD
Leukemia; 2005 Nov; 19(11):1941-7. PubMed ID: 16094422
[TBL] [Abstract][Full Text] [Related]
4. Multiple mechanisms induce ectopic expression of LYL1 in subsets of T-ALL cell lines.
Nagel S; Venturini L; Meyer C; Kaufmann M; Scherr M; Drexler HG; MacLeod RA
Leuk Res; 2010 Apr; 34(4):521-8. PubMed ID: 19608273
[TBL] [Abstract][Full Text] [Related]
5. [Identification of interaction partners and function analysis of new splicing product of human LMO2 gene].
Yuan W; Yang S; Sun W; Du J; Zhai CL; Wang ZQ; Zhu TH
Zhonghua Xue Ye Xue Za Zhi; 2008 May; 29(5):325-8. PubMed ID: 18844071
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the relationship between Scl transcription factor complex protein expression patterns and the effects of LiCl on ATRA-induced differentiation in blast cells from patients with acute myeloid leukemia.
Rice AM; Holtz KM; Karp J; Rollins S; Sartorelli AC
Leuk Res; 2004 Nov; 28(11):1227-37. PubMed ID: 15380350
[TBL] [Abstract][Full Text] [Related]
7. A new 2-aminosteroid induces cellular differentiation and upregulates the expression of MafB and Egr-1 genes respectively in HL-60 and K562 leukemia cells.
He Q; Li Q; Yuan LB; He J
Chin Med J (Engl); 2005 Jan; 118(2):91-9. PubMed ID: 15667792
[TBL] [Abstract][Full Text] [Related]
8. [The down regulation of VEGF gene expression may link to change the expression profile of genes in leukemia cell line K562].
Xu WL; Shen HL; Wu ZY; Tang HR; Wang FC
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Feb; 23(1):37-42. PubMed ID: 16456783
[TBL] [Abstract][Full Text] [Related]
9. Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL.
McCormack MP; Shields BJ; Jackson JT; Nasa C; Shi W; Slater NJ; Tremblay CS; Rabbitts TH; Curtis DJ
Blood; 2013 Sep; 122(12):2093-103. PubMed ID: 23926305
[TBL] [Abstract][Full Text] [Related]
10. Suspected leukemia oncoproteins CREB1 and LYL1 regulate Op18/STMN1 expression.
San-Marina S; Han Y; Liu J; Minden MD
Biochim Biophys Acta; 2012; 1819(11-12):1164-72. PubMed ID: 23000483
[TBL] [Abstract][Full Text] [Related]
11. Ectopic retroviral expression of LMO2, but not IL2Rgamma, blocks human T-cell development from CD34+ cells: implications for leukemogenesis in gene therapy.
Pike-Overzet K; de Ridder D; Weerkamp F; Baert MR; Verstegen MM; Brugman MH; Howe SJ; Reinders MJ; Thrasher AJ; Wagemaker G; van Dongen JJ; Staal FJ
Leukemia; 2007 Apr; 21(4):754-63. PubMed ID: 17268520
[TBL] [Abstract][Full Text] [Related]
12. Assembly of the oncogenic DNA-binding complex LMO2-Ldb1-TAL1-E12.
Ryan DP; Duncan JL; Lee C; Kuchel PW; Matthews JM
Proteins; 2008 Mar; 70(4):1461-74. PubMed ID: 17910069
[TBL] [Abstract][Full Text] [Related]
13. [Expression of pig7 in acute leukemia and its clinical significance].
Wang DH; Wang Y; Wang M; Liu H; Xu ZF; Rao Q; Meng JH; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):532-6. PubMed ID: 18078129
[TBL] [Abstract][Full Text] [Related]
14. DCC protein expression in hematopoietic cell populations and its relation to leukemogenesis.
Inokuchi K; Miyake K; Takahashi H; Dan K; Nomura T
J Clin Invest; 1996 Feb; 97(3):852-7. PubMed ID: 8609244
[TBL] [Abstract][Full Text] [Related]
15. The expression of LMO2 protein in acute B-cell and myeloid leukemia.
Cobanoglu U; Sonmez M; Ozbas HM; Erkut N; Can G
Hematology; 2010 Jun; 15(3):132-4. PubMed ID: 20557670
[TBL] [Abstract][Full Text] [Related]
16. Expression and clinical implications of the soluble drug resistance-related calcium-binding protein (sorcin) gene in leukemia patients.
Li G; Tan Y; Yang C; Zhao C; Zhao H; Wang J; Xue Y; Han M; Qian L; Zhao C
Zhonghua Xue Ye Xue Za Zhi; 2002 Jun; 23(6):293-6. PubMed ID: 12411058
[TBL] [Abstract][Full Text] [Related]
17. Expression and clinical implication of soluble resistance-associated calcium-binding protein gene and multi-drug resistance gene in leukemia.
Li G; Tan Y; Yang C; Zhao C; Zhao H; Wang J; Xue Y; Han M; Qian L; Zhao C
Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):370-4. PubMed ID: 12408767
[TBL] [Abstract][Full Text] [Related]
18. Angiopoietin-2 is a direct transcriptional target of TAL1, LYL1 and LMO2 in endothelial cells.
Deleuze V; El-Hajj R; Chalhoub E; Dohet C; Pinet V; Couttet P; Mathieu D
PLoS One; 2012; 7(7):e40484. PubMed ID: 22792348
[TBL] [Abstract][Full Text] [Related]
19. Membrane protein hMYADM preferentially expressed in myeloid cells is up-regulated during differentiation of stem cells and myeloid leukemia cells.
Wang Q; Li N; Wang X; Shen J; Hong X; Yu H; Zhang Y; Wan T; Zhang L; Wang J; Cao X
Life Sci; 2007 Jan; 80(5):420-9. PubMed ID: 17097684
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional control of fetal liver hematopoiesis: dominant negative effect of the overexpression of the LIM domain mutants of LMO2.
Terano T; Zhong Y; Toyokuni S; Hiai H; Yamada Y
Exp Hematol; 2005 Jun; 33(6):641-51. PubMed ID: 15911088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]